ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 2588

$724K Total Retail Price of All Prescriptions

Rank: 214 out of 2588

533 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 13,082 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 604 574 1 2
FUROSEMIDE 600 590 2 5
ATORVASTATIN CALCIUM 549 537 3 11
HYDROCHLOROTHIAZIDE 443 428 4 13
OMEPRAZOLE 437 419 5 6
AMLODIPINE BESYLATE 413 401 6 4
SIMVASTATIN 406 370 7 1
HYDROCODONE-ACETAMINOPHEN 355 287 S3 8 7
METOPROLOL TARTRATE 344 340 9 9
DONEPEZIL HCL 337 337 10 22
LISINOPRIL 318 297 11 3
METOPROLOL SUCCINATE 302 271 12 12
WARFARIN SODIUM 244 236 13 10
NAMENDA 235 235 14 32
LANTUS SOLOSTAR 221 221 15 93
CITALOPRAM HBR 220 220 16 27
KLOR-CON M20 214 214 17 52
DIGOXIN 188 183 18 38
METFORMIN HCL 181 169 19 8
DIOVAN 171 171 20 29
JANTOVEN 161 132 21 267
ZETIA 161 158 21 69
ALENDRONATE SODIUM 145 145 23 21
LOSARTAN POTASSIUM 143 143 24 17
SERTRALINE HCL 143 133 24 26
ALLOPURINOL 143 143 24 33
GABAPENTIN 140 137 27 18
ZOLPIDEM TARTRATE 129 123 28 24
NOVOLOG FLEXPEN 124 122 29 205
AZITHROMYCIN 123 117 30 45
ATENOLOL 122 120 31 14
MIRTAZAPINE 116 116 32 63
TAMSULOSIN HCL 110 110 33 23
GLIMEPIRIDE 106 106 34 39
ESCITALOPRAM OXALATE 101 101 35 68
CLOPIDOGREL 99 92 36 30
KLOR-CON 10 89 89 37 75
TRAMADOL HCL 89 89 37 19
POTASSIUM CHLORIDE 86 86 39 15
ADVAIR DISKUS 85 85 40 48
LIDODERM 81 80 41 86
OXYBUTYNIN CHLORIDE ER 78 74 42 85
PANTOPRAZOLE SODIUM 75 71 43 28
FLUTICASONE PROPIONATE 74 74 44 40
PLAVIX 72 67 45 43
CARVEDILOL 69 65 46 20
VYTORIN 66 66 47 200
LANTUS 65 60 48 47
ENALAPRIL MALEATE 64 60 49 31
PREDNISONE 64 62 49 42
TRIAMTERENE-HCTZ 63 63 51 46
LIPITOR 60 50 52 114
SYNTHROID 60 60 52 88
LEXAPRO 58 58 54 182
CLOTRIMAZOLE-BETAMETHASONE 56 43 55 155
ISOSORBIDE MONONITRATE ER 55 55 56 49
QUETIAPINE FUMARATE 54 54 57 74
SPIRONOLACTONE 54 54 57 58
POLYETHYLENE GLYCOL 3350 52 52 59 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.